BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14694301)

  • 1. Malignant fibrous histiocytoma of the extremities and trunk: an institutional review.
    Peiper M; Zurakowski D; Knoefel WT; Izbicki JR
    Surgery; 2004 Jan; 135(1):59-66. PubMed ID: 14694301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
    Zagars GK; Mullen JR; Pollack A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):983-94. PubMed ID: 8600111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant fibrous histiocytoma: an institutional review.
    Gibbs JF; Huang PP; Lee RJ; McGrath B; Brooks J; McKinley B; Driscoll D; Kraybill WG
    Cancer Invest; 2001; 19(1):23-7. PubMed ID: 11291552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoid tumors of the trunk and extremity.
    Karakousis CP; Mayordomo J; Zografos GC; Driscoll DL
    Cancer; 1993 Sep; 72(5):1637-41. PubMed ID: 8348495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in patients with malignant fibrous histiocytoma of the extremities].
    Atalar H; Başarir K; Yildiz Y; Sağlik Y
    Acta Orthop Traumatol Turc; 2007; 41(4):271-6. PubMed ID: 18180555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
    Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
    Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial soft tissue sarcomas of the extremities and trunk.
    Lachenmayer A; Yang Q; Eisenberger CF; Boelke E; Poremba C; Heinecke A; Ohmann C; Knoefel WT; Peiper M
    World J Surg; 2009 Aug; 33(8):1641-9. PubMed ID: 19430830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-team experience of limb sparing approach in adults with high-grade malignant fibrous histiocytoma.
    Issakov J; Kollender Y; Soyfer V; Bickels J; Flusser G; Meller I; Merimsky O
    Oncol Rep; 2005 Oct; 14(4):1071-6. PubMed ID: 16142374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in 227 patients with malignant fibrous histiocytoma.
    Pezzi CM; Rawlings MS; Esgro JJ; Pollock RE; Romsdahl MM
    Cancer; 1992 Apr; 69(8):2098-103. PubMed ID: 1311983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results and prognostic factors in patients with malignant fibrous histiocytoma.
    Hsu HC; Huang EY; Wang CJ
    Acta Oncol; 2004; 43(6):530-5. PubMed ID: 15370609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrative subcutaneous malignant fibrous histiocytoma: a comparative study with deep malignant fibrous histiocytoma and an observation of biologic behavior.
    Fanburg-Smith JC; Spiro IJ; Katapuram SV; Mankin HJ; Rosenberg AE
    Ann Diagn Pathol; 1999 Feb; 3(1):1-10. PubMed ID: 9990107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of surgery for malignant fibrous histiocytomas of soft tissue.
    Matsumoto S; Ahmed AR; Kawaguchi N; Manabe J; Matsushita Y
    Int J Clin Oncol; 2003 Apr; 8(2):104-9. PubMed ID: 12720103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant fibrous histiocytoma: a retrospective study of 109 cases.
    Belal A; Kandil A; Allam A; Khafaga Y; El-Husseiny G; El-Enbaby A; Memon M; Younge D; Moreau P; Gray A; Schultz H
    Am J Clin Oncol; 2002 Feb; 25(1):16-22. PubMed ID: 11823689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial growth of human malignant fibrous histiocytoma xenografts in immunodeficient mice.
    Kurihara N; Kubota T; Otani Y; Watanabe M; Kumai K; Kitajima M
    Surg Today; 1996; 26(4):267-70. PubMed ID: 8727948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
    Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
    Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
    Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
    Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant fibrous histiocytoma of the limbs.
    Lee SY; Kim SS; Jeon DG; Baek GH
    Int Orthop; 1993; 17(3):173-5. PubMed ID: 8393429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
    Pisters PW; Pollock RE; Lewis VO; Yasko AW; Cormier JN; Respondek PM; Feig BW; Hunt KK; Lin PP; Zagars G; Wei C; Ballo MT
    Ann Surg; 2007 Oct; 246(4):675-81; discussion 681-2. PubMed ID: 17893504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
    Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
    Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.